Shares of a 3% dividend yield, solid blue-chip drug company are valuable in shaky economic times.
Amylin is upgraded to 'equal weight,' and Research In Motion is downgraded to 'underweight.'
The transaction also includes a $3.4 billion payment from AstraZeneca as the big drug companies try to replace lost sales from products with generic competition.
Stocks dip as a key manufacturing index unexpectedly contracts for the first time in nearly 3 years.
TiVo is downgraded to 'neutral,' and Facebook is initiated with a 'buy.'
Mergers and acquisitions activity is heating up among big pharma and biotechs.
Political uncertainty in Europe and allegations of bribery at Wal-Mart kick the week off on a sour note.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Low interest rates are supposed to get money circulating, but instead investors are hoarding cash.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
'We are sitting ourselves to death,' a doctor says in a new book, and obesity isn't the only risk.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'